Ocular Therapeutix grants director Riad Sherif 28,000 restricted stock units
OCUL•Ocular Therapeutix granted director Riad Sherif 28,000 common shares on November 6, 2026, and options to buy 88,000 shares at $6.60 each, expiring November 5, 2036.
1. Director awards
Ocular Therapeutix granted director Sherif Riad 28,000 common shares on November 6, 2026. He also received options to buy 88,000 common shares at an exercise price of $6.60; the options expire November 5, 2036.
